Adil Aftab: Anticoagulation in CKD – Key Updates from the 2026 ESC Guidelines
Adil Aftab, Postgraduate Trainee at People’s University of Medical and Health Sciences for Women, Nawabshah, shared a post on LinkedIn:
“Anticoagulation in CKD: Key Updates from the 2026 ESC Guidelines
The 2026 ESC Guidelines for the management of cardiovascular disease and chronic kidney disease highlight the importance of individualized anticoagulation decisions in patients with chronic kidney disease (CKD) and either venous thromboembolism (VTE) or atrial fibrillation (AF).
- Renal function matters: Anticoagulant selection should be tailored according to eGFR and bleeding/thromboembolic risk.
- AF: Factor Xa inhibitors are generally preferred in patients with eGFR 30–59 mL/min/1.73 square meters.
- Advanced CKD: At eGFR below 30, treatment becomes increasingly individualized, with careful consideration of bleeding risk and available evidence.
- Dialysis: Decisions regarding anticoagulation require particularly careful risk–benefit assessment because evidence remains limited.
- VTE: Factor Xa inhibitors may be preferred over LMWH or VKA in selected CKD stages, while very advanced CKD requires individualized decision-making.
This guideline reinforces an important clinical principle: anticoagulation in CKD is not ‘one size fits all.’ Renal function, indication, thromboembolic risk, bleeding risk, and the specific anticoagulant all need to be considered.
A valuable update for clinicians involved in Internal Medicine, Cardiology, Nephrology, and Hematology.”
Stay updated with Hemostasis Today.
-
Oct 22, 2026, 15:37Alina Mitina: Key Concerns Surrounding DVT and Pulmonary Embolism
-
Oct 22, 2026, 14:45Seyed Mehrab Safdari: Prenatal Diagnosis in Hemophilia – Two Decades of Progress and Remaining Challenges
-
Oct 22, 2026, 14:39Mahmoud Abdelnabi: Evaluating the Evidence on Elevated Lp(a) and VTE Before Clinical Translation
-
Oct 22, 2026, 14:34David McIntosh: Fundamental Flaws in National Blood Systems Are Root Causes of Failure
-
Oct 22, 2026, 14:32Aurelio Maggio: Bridging Scientific Progress and Equitable Access to SCD Care in Sub-Saharan Africa
-
Oct 22, 2026, 14:26Khaled Musallam: Longevity and Healthy Aging in Thalassemia
-
Oct 22, 2026, 14:26Deise Catamo Vaz: Two Years of Growth and a New Way of Seeing the World of Stroke
-
Oct 22, 2026, 14:24Yara Mohamed: A Silent Killer Plots his Victim’s Death Over Years
-
Oct 22, 2026, 14:19Shailendra Singh: Two Different Pulmonary Embolism Cases, One Critically Important Lesson